Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

MicroRNA Are Useful Biomarkers for Prediction of Response to Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma.

Alvaro J. Alencar, MD, Raquel Malumbres, PhD., Ranjana Advani, MD, Neha Talreja, Ragini Shyam, Javier Briones, Yaso Natkunam, Randy D. Gascoyne, MD, Robert Tibshirani, PhD., Izidore S. Lossos, MD, PhD

Blood (2009) 114 (22): 624.

https://doi.org/10.1182/blood.V114.22.624.624

Published: 2009

Journal Articles

Neither CD68+ Nor CD163+ Macrophages Are Associated with Decreased Survival in Follicular Lymphoma

Di ta Gratzinger, MD, PhD, Weiyun Ai, MD, PhD, Robert Tibshirani, PhD., R. Levy, Y. Natkunam

Blood (2008) 112 (11): 3747.

https://doi.org/10.1182/blood.V112.11.3747.3747

Published: 2008

Journal Articles

Lymphoma-Expressed VEGF-a, VEGFR-1, VEGFR-2, and Microvessel Density Are Not Predictive of Overall Survival in Follicular Lymphoma

Dita Gratzinger, MD, PhD, S. Zhao, Weiyun Ai, MD, PhD, Robert Tibshirani, PhD., Ronald Levy, MD, Y. Natkunam

Blood (2008) 112 (11): 3767.

https://doi.org/10.1182/blood.V112.11.3767.3767

Published: 2008

Journal Articles

Differentiation-Stage-Specific Expression of MicroRNAs in B-Lymphocytes and Diffuse Large B-Cell Lymphomas (DLBCL)

Raquel Malumbres, PhD., Robert Tibshirani, PhD., Elena Cubedo, PhD., Kristopher A Sarosiek, BS, Xiaoyu Jiang, PhD., Jose Ruiz, MD, Izidore Lossos, MD

Blood (2008) 112 (11): 805.

https://doi.org/10.1182/blood.V112.11.805.805

Published: 2008

Journal Articles

Anti-Idiotype Antibody Response after Vaccination Correlates with Better Overall Survival in Follicular Lymphoma.

Wei Z. Ai, MD, PhD, Robert Tibshirani, PhD, Behnaz Taidi, Bsc, Debra Czerwinski, Bsc, Ronald Levy, MD

Blood (2007) 110 (11): 647.

https://doi.org/10.1182/blood.V110.11.647.647

Published: 2007

Journal Articles

Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.

Daryl Tan, MD, Saul A. Rosenberg, MD, Ronald Levy, MD, Philip Lavori, PhD, Robert Tibshirani, PhD, Richard T. Hoppe, MD, Roger Warnke, MD, Ranjana Advani, MD, Yasodha Natkunam, MD, Alan Yuen, MD, Sandra J. Horning, MD

Blood (2007) 110 (11): 3428.

https://doi.org/10.1182/blood.V110.11.3428.3428

Published: 2007

Journal Articles

Preliminary Report on a Phase I/II Study of Intratumoral Injection of PF-3512676 (CpG 7909), a TLR9 Agonist, Combined with Radiation in Recurrent Low-Grade Lymphomas.

Wei Yun Z. Ai, MD, PhD, Youn Kim, MD, Richard T. Hoppe, MD, Sumit Shah, Bsc, Sandra J. Horning, MD, Robert Tibshirani, PhD, Ronald Levy, MD

Blood (2006) 108 (11): 2716.

https://doi.org/10.1182/blood.V108.11.2716.2716

Published: 2006

Journal Articles

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman J. Lacayo, MD, Maureen O’Brien, MD, Shweta Jain, Soheil Meshinchi, MD, PhD, Ron Yu, PhD, Dejan Juric, MD, Myron N. Chang, PhD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Howard J. Weinstein, MD, Branimir I. Sikic, MD, Gary Van Houten Dahl, MD

Blood (2006) 108 (11): 1915.

https://doi.org/10.1182/blood.V108.11.1915.1915

Published: 2006

Journal Articles

Tumor-Infiltrating T Cells Are Not Predictive of Clinical Outcome in Follicular Lymphoma.

Wei Yun Z. Ai, MD, PhD, Debra Czerwinski, Bsc, Sandra J. Horning, MD, John Allen, Bsc, Robert Tibshirani, PhD, Ronald Levy, MD

Blood (2006) 108 (11): 824.

https://doi.org/10.1182/blood.V108.11.824.824

Published: 2006

Journal Articles

A FLT3 Gene-Expression Signature Outperforms FLT3 Status in Predicting Clinical Outcome for Patients with Normal Karyotype AML.

Lars Bullinger, MD, Konstanze Dohner, MD, Christoph Stirner, Frank G. Rucker, MD, Stefan Frohling, MD, Young H. Kim, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2006) 108 (11): 2311.

https://doi.org/10.1182/blood.V108.11.2311.2311

Published: 2006

Journal Articles

Gene Expression Profiling and FLT3 Status Correlate with Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman Lacayo, MD, Soheil Meshinchi, MD, Susana Raimondi, PhD, Chitra Saraiya, MS, Maureen O’Brien, MD, Ronald Yu, PhD, Dejan Juric, MD, Myron Chang, PhD, Cheryl Willman, MD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Branimir Sikic, MD, Howard Weinstein, MD, Gary Van Houten Dahl, MD

Blood (2005) 106 (11): 2372.

https://doi.org/10.1182/blood.V106.11.2372.2372

Published: 2005

Journal Articles

Differential Gene Expression Profiles in CD34+ Myelodysplastic Syndrome Marrow Cells.

Kunju Sridhar, PhD, Patrick O. Brown, MD, PhD, Robert Tibshirani, PhD, Catriona Jamieson, MD, PhD, Irv Weissman, MD, Douglas T. Ross, MD, PhD, Peter L. Greenberg, MD

Blood (2005) 106 (11): 3424.

https://doi.org/10.1182/blood.V106.11.3424.3424

Published: 2005

Journal Articles

Prognostic Gene-Expression Signatures in Adult Acute Myeloid Leukemia with Normal Karyotype.

Lars Bullinger, MD, Eric Bair, PhD, Raphael Kranz, Konstanze Dohner, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2005) 106 (11): 756.

https://doi.org/10.1182/blood.V106.11.756.756

Published: 2005

Journal Articles

Gene Expression Profiling Identifies Genes Associated with In Vitro Resistance to Daunorubicin and Cytarabine in Children with De Novo Acute Myelogenous Leukemia (AML) from the Pediatric Oncology Group (POG) Study # 9421.

Dennis J. Kuo, MD, Norman J. Lacayo, MD, Steven Buck, MS, Ron Yu, MA, Chitra Saraiya, MS, Lorrie Douglas, BS, Howard Weinstein, MD, Myron Chang, MD, Cheryl L. Willman, MD, Robert Tibshirani, PhD, Gary V. Dahl, MD, Branimir Sikic, MD, Yaddanapudi Ravindranath, MD

Blood (2004) 104 (11): 1130.

https://doi.org/10.1182/blood.V104.11.1130.1130

Published: 2004

Journal Articles

Identification of Distinct inv(16) Subclasses in Adult Acute Myeloid Leukemia Based on Gene Expression Profiling.

Lars Bullinger, MD, Claudia Scholl, MD, Eric Bair, Konstanze Dohner, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2004) 104 (11): 2037.

https://doi.org/10.1182/blood.V104.11.2037.2037

Published: 2004

Journal Articles

FLT3 Mutations Determine the Clinical Outcome in Children with De Novo Acute Myelogenous Leukemia (AML) and Normal Karyotype: Pediatric Oncology Group (POG) Study # 9421.

Norman J. Lacayo, MD, Soheil Meshinchi, MD, PhD, Susana C. Raimondi, PhD, Dennis J. Kuo, MD, Ron Yu, MA, Myron N. Chang, PhD, Cheryl L. Willman, MD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Branimir I. Sikic, MD, Howard Weinstein, MD, Gary V. Dahl, MD

Blood (2004) 104 (11): 570.

https://doi.org/10.1182/blood.V104.11.570.570

Published: 2004

NARROW

MicroRNA Are Useful Biomarkers for Prediction of Response to Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma.

Neither CD68+ Nor CD163+ Macrophages Are Associated with Decreased Survival in Follicular Lymphoma

Lymphoma-Expressed VEGF-a, VEGFR-1, VEGFR-2, and Microvessel Density Are Not Predictive of Overall Survival in Follicular Lymphoma

Differentiation-Stage-Specific Expression of MicroRNAs in B-Lymphocytes and Diffuse Large B-Cell Lymphomas (DLBCL)

Anti-Idiotype Antibody Response after Vaccination Correlates with Better Overall Survival in Follicular Lymphoma.

Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.

Preliminary Report on a Phase I/II Study of Intratumoral Injection of PF-3512676 (CpG 7909), a TLR9 Agonist, Combined with Radiation in Recurrent Low-Grade Lymphomas.

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Tumor-Infiltrating T Cells Are Not Predictive of Clinical Outcome in Follicular Lymphoma.

A FLT3 Gene-Expression Signature Outperforms FLT3 Status in Predicting Clinical Outcome for Patients with Normal Karyotype AML.

Gene Expression Profiling and FLT3 Status Correlate with Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Differential Gene Expression Profiles in CD34+ Myelodysplastic Syndrome Marrow Cells.

Prognostic Gene-Expression Signatures in Adult Acute Myeloid Leukemia with Normal Karyotype.

Gene Expression Profiling Identifies Genes Associated with In Vitro Resistance to Daunorubicin and Cytarabine in Children with De Novo Acute Myelogenous Leukemia (AML) from the Pediatric Oncology Group (POG) Study # 9421.

Identification of Distinct inv(16) Subclasses in Adult Acute Myeloid Leukemia Based on Gene Expression Profiling.

FLT3 Mutations Determine the Clinical Outcome in Children with De Novo Acute Myelogenous Leukemia (AML) and Normal Karyotype: Pediatric Oncology Group (POG) Study # 9421.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only